C12Y 304/17
Metallocarboxypeptidases
Official title: Metallocarboxypeptidases (3.4.17)
C12Y304/17 (Metallocarboxypeptidases) appears on 113 US grants and 301 published applications in this corpus.
Search patents in C12Y- Granted patents
- 113
- Published applications
- 301
- Assignees
- 193
- Inventors
- 778
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 2 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 4 |
| 2012 | 0 | 2 |
| 2013 | 0 | 4 |
| 2014 | 2 | 3 |
| 2015 | 5 | 8 |
| 2016 | 3 | 11 |
| 2017 | 8 | 14 |
| 2018 | 4 | 9 |
| 2019 | 7 | 12 |
| 2020 | 8 | 21 |
| 2021 | 11 | 24 |
| 2022 | 10 | 28 |
| 2023 | 13 | 68 |
| 2024 | 15 | 41 |
| 2025 | 13 | 33 |
| 2026 | 6 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 304/17021Glutamate carboxypeptidase ii43
- C12Y 304/17023Angiotensin-converting enzyme 243
- C12Y 304/17001Carboxypeptidase a10
- C12Y 304/17002Carboxypeptidase b9
- C12Y 304/17011Glutamate carboxypeptidase7
- C12Y 304/17003Lysine carboxypeptidase3
- C12Y 304/17004Gly-xaa carboxypeptidase3
- C12Y 304/17006Alanine carboxypeptidase3
All 20 subgroupsShow fewer
- C12Y 304/17017Tubulinyl-tyr carboxypeptidase2
- C12Y 304/17008Muramoylpentapeptide carboxypeptidase0
- C12Y 304/1701Carboxypeptidase e0
- C12Y 304/17012Carboxypeptidase m0
- C12Y 304/17013Muramoyltetrapeptide carboxypeptidase0
- C12Y 304/17014Zinc d-ala-d-ala carboxypeptidase0
- C12Y 304/17015Carboxypeptidase a20
- C12Y 304/17016Membrane pro-xaa carboxypeptidase0
- C12Y 304/17018Carboxypeptidase t0
- C12Y 304/17019Carboxypeptidase taq0
- C12Y 304/1702Carboxypeptidase u0
- C12Y 304/17022Metallocarboxypeptidase d0
Recent patents
- Non-human animals comprising a humanized ACE2 locus11 Aug 2026US 12,702,122 B2Regeneron Pharmaceuticals, Inc.
- Soluble ACE2 protein, fusion proteins thereof with an FC domain, and methods of treatment of an ACE2-related disease21 Jul 2026US 12,686,860 B2Huahui Health Ltd.
- ACE2 muteins and methods of using the same7 Jul 2026US 12,674,153 B2Emmune, Inc.
- Hydrolyzed collagen for use in reducing blood glucose26 May 2026US 12,636,339 B2Rousselot B.V.
- Method of treating covid-19 infection using superparamagnetic iron oxide nanoparticle19 May 2026US 12,629,392 B2Imam Abdulrahman Bin Faisal University
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Method for treating covid-19 infection in a human subject10 Sep 2026US 2026/0263510 A1Imam Abdulrahman Bin Faisal University
- Hydrolyzed collagen for use in reducing blood glucose27 Aug 2026US 2026/0248875 A1Rousselot B.V.
- Novel coronavirus protective nasal spray, and preparation and use thereof20 Aug 2026US 2026/0242763 A1Sichuan Clover Biopharmaceuticals, Inc.
- Use of carboxypeptidase e/neurotrophic factor-alpha1 to treat neurodegenerative disease16 Jul 2026US 2026/0199441 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Induced activation in dendritic cell40US 7,404,950 B2Baylor College of Medicine · 2008
- Method for preparing cheese flavor concentrate35US 4,708,876 AFuji Oil Company, Limited · 1987
- Induced activation in dendritic cells35US 8,999,949 B2Baylor College of Medicine · 2015
- PSMA binding ligand-linker conjugates and methods for using34US 9,951,324 B2Purdue Research Foundation · 2018
- Induced activation in dendritic cells33US 8,771,671 B2Baylor College of Medicine · 2014